Lung Cancer

You are here

Lung Cancer

If you have been NEWLY DIAGNOSED  START HERE 

Video Library

Case Based Panel Discussion - Advanced Non Squamous NSCLC, High PD-L1, No Driver Mutation - What is the Optimal 1st Line?
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal 1st line treatment for a patient with advanced non squamous non small cell lung cancer, high PD-L1, and no driver mutation.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Maintenance Therapy, Adjuvant Therapy, Targeted Therapy, Immunotherapies
Case Based Panel Discussion - Advanced Non Squamous NSCLC, Low PD-L1 No Driver Mutation - Is There a Best Systemic Therapy Option?
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss if there is a best systemic therapy option for a patient with advanced non-squamous NSCLC, low PD-L1 and no driver mutation.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Maintenance Therapy, Adjuvant Therapy, Targeted Therapy, Immunotherapies
Case Based Panel Discussion - What is the Optimal Approach for a Fit Patient with Advanced Squamous NSCLC and Low Tumor PD-L1 Expression
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the optimal approach for a fit patient with advanced squamous NSCLC and low tumor PD-L1 expression.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
General Lung Cancer, Non Small Cell Lung Cancer, Chemotherapy, Immunotherapies, Adjuvant Therapy, 3rd Line and beyond, Targeted Therapy
Case Based Panel Discussion - Choosing Between Targeted Therapy and Immunotherapy in a Patient with an EGFR Mutation and High PDL-1 Expression
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss the treatment choice between targeted therapy and immunotherapy in a patient with an EGFR Mutation and high PDL-1.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, General Lung Cancer, Non Small Cell Lung Cancer, Immunotherapies
Case Based Panel Discussion - Metastatic Squamous NSCLC Low Tumor PD-L1 Frail Patient - Treatment?
Drs Zofia Piotrowska, H. Jack West, and Taofeek Owonikoko sit down to discuss a series of case-based scenarios. In this video, the doctors discuss a frail patient with metastatic squamous NSCLC with low tumor PD-L1 expression, and the best treatment approach for this patient.
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Aging and Elderly, General Lung Cancer, Non Small Cell Lung Cancer, Tumor Marker Tests, Immunotherapies, Chemotherapy

Articles

2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Watch the LIVE WEBCAST starting at 1 pm, Eastern, Saturday, November 18, 2017 in partnership with Georgetown University Hospital, GRACE presents: 2017 Advances in Immunotherapy: What Lung Cancer Patients Need to Know
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Immunotherapies, Investigational Agents, Clinical Trials
Retrospective Data and Real World Evidence: The Poor Stepchild of Clinical Trials?
Many physicians worship evidence-based medicine, which is generally a very good practice that ensures that medical practice isn’t dictated by our...
Cancer Journey:
Cancer Type:
Lung Cancer, Blood Cancers, Head and Neck Cancer, Other
Disease Learning:
Clinical Trials
My Top 10 ASCO 2017 Lung Cancer Presentations
Over the next few days, about 30,000 oncologists and other cancer care professionals, along with a growing number of patient advocates, are...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Non Small Cell Lung Cancer, Small Cell Lung Cancer
New FDA Approval for Zykadia (ceritinib) for ALK-Positive NSCLC: Why I Think It's a Poor Choice for Initial Treatment
The FDA just approved a new therapy for the approximately 4% of patients with NSCLC who have the molecular marker known as an ALK rearrangement. The...
Cancer Journey:
Just Diagnosed, In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy, Targeted Therapies – ALK
Targeted Therapies Patient Forum September 2017 Speaker Highlight - James Stevenson, MD
GRACE is excited to continue to build the faculty and agenda for the upcoming Targeted Therapies Patient Forum, September 16, 2017. See more information about our presenters in Speaker Highlights - today we introduce James Stevenson, MD.
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapy

Community Forum

Tough decision between a whole brain radiation vs occipital craniotomy
My wife is experiencing a second time brain tumor recurrence. She had her first occipital craniotomy back in 2011. On late Oct 2013 she began to...
Cancer Journey:
In Treatment, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, General Lung Cancer, Symptoms, Pain Medication, Procedures & Treatments, Maintenance Therapy, Radiation Therapy, Non Small Cell Lung Cancer
Alternative medicine
My father has been dealing with prostate cancer for a couple of years now and is about to begin treatment. Does anybody have any information or...
Cancer Journey:
Cancer Type:
Disease Learning:
Chemotherapy
Vaxira for stage 4 NSCLC
Has anyone any information on obtaining and using Vaxira, the Cuban drug, for stage 4 advanced NSCLC? Not sure if US citizens can still travel to...
Cancer Journey:
In Treatment
Cancer Type:
Lung Cancer
Disease Learning:
ANGIOGENESIS, 3rd Line and beyond, Targeted Therapy, Investigational Agents, Non Small Cell Lung Cancer
Can Tagrisso be used in additional to Alimta maintenance
My wife was on Tarceva for over 6 1/2 years. Then she developed acquired resistance to Tarceva with prevascular and supraclevical lymph nodes...
Cancer Journey:
Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Targeted Therapies - EGFR, Biopsy/Tissue Collection, Maintenance Therapy, Non Small Cell Lung Cancer
Tagrisso for acquired resistance to Tarceva
My wife has come a long way with Stage IV lung cancer since 2010. She has now developed acquired resistance to Tarceva. Gene sequence of biopsy from...
Cancer Journey:
Just Diagnosed, In Treatment, Survivorship
Cancer Type:
Lung Cancer
Disease Learning:
Lung Cancer, Targeted Therapies - EGFR, Targeted Therapy, Non Small Cell Lung Cancer